{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:34:02Z","timestamp":1787168042631,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clindermatol.2023.10.005","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T11:26:07Z","timestamp":1698319567000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes"],"prefix":"10.1016","volume":"42","author":[{"given":"Zeynep","family":"Bas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.10.005_bib0001","series-title":"Intraocular Tumors: A Text and Atlas","first-page":"95","article-title":"Posterior uveal melanoma: clinical features","author":"Shields","year":"2016"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0002","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0003","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0004","first-page":"30","article-title":"Updated AJCC classification for posterior uveal melanoma","volume":"4","author":"Baron","year":"2018","journal-title":"Retina Today"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0005","doi-asserted-by":"crossref","first-page":"1113\u20111120","DOI":"10.1038\/ng.2764","article-title":"Cancer Genome Atlas Research Network: the Cancer Genome Atlas Pan\u2011Cancer Analysis Project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0006","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0007","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ophtha.2018.03.011","article-title":"The Cancer Genome Atlas Project: an integrated molecular view of uveal melanoma","volume":"125","author":"Jager","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0008","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ophtha.2019.04.027","article-title":"Genetic analysis of uveal melanoma in 658 patients using The Cancer Genome Atlas classification of uveal melanoma as A, B, C, and D","volume":"126","author":"Vichitvejpaisal","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0009","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4103\/ijo.IJO_313_21","article-title":"Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases","volume":"69","author":"Shields","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2021.11.018","article-title":"Adding The Cancer Genome Atlas chromosome classes to American Joint Committee on Cancer system offers more precise prognostication in uveal melanoma","volume":"129","author":"Gelmi","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0011","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ophtha.2021.11.011","article-title":"Chromosome 3 and 8q aberrations in uveal melanoma show greater impact on survival in patients with light iris versus dark iris color","volume":"129","author":"Wierenga","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0012","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaoncol.2018.2895","article-title":"Conditional survival as a pragmatic resource for cancer survivors and health care professionals","volume":"4","author":"Thomas","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0013","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.oret.2020.09.015","article-title":"Conditional survival in uveal melanoma","volume":"5","author":"Zabor","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0014","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4103\/sjopt.sjopt_69_21","article-title":"Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification in 1001 cases","volume":"36","author":"Shields","year":"2021","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ophtha.2017.08.017","article-title":"Adjuvant Sunitinib in high-risk patients with uveal melanoma: comparison with institutional controls","volume":"125","author":"Valsecchi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0016","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2023.10.005_bib0017","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.ophtha.2016.06.027","article-title":"Adjuvant dendritic cell vaccination in high-risk uveal melanoma","volume":"123","author":"Bol","year":"2016","journal-title":"Ophthalmology"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:37Z","timestamp":1760034097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23001700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0738081X23001700"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cancer Genome Atlas for uveal melanoma is predictive of patient outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}